🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic oral presentation by Dr. Oluloro about how we measure equitable access in clinical trials for Black and BrownWomen socialsituation as exclusion???#fixcomorbiditycriteria#letsequalizetheentrycriteria @#sgo2023 #SGOMtg

⁦Matt Powell⁩ ⁦Angeles Secord⁩ & I are so excited to see you all at @sgo2024 in 🌞 San Diego! Pls don’t forget to register- Early bird registration ends tmw! ⁦SGO⁩ ⁦ASCO⁩ ⁦IGCS⁩ ⁦The GOG Foundation Inc.⁩ ⁦ACOG⁩ ⁦Perlmutter Cancer Center at NYU Langone Health⁩

Excited to see everyone in San Diego! Patients can register too! March 16-18, 2024 in San Diego: sgo.org/events/annual-… ⁦SGO⁩ ⁦GYN Cancer | #GYNCSM⁩ ⁦⁦The GOG Foundation Inc.⁩ ⁦IGCS⁩ ⁦ASCO⁩ ⁦NRG Oncology⁩ ⁦SHARE Cancer Support⁩

#SGO2024 come for the science, stay for the beer! Two great #SGOAnnualMeeting in two great beer towns! #SGOTampa #SGOSanDiego

#SGOAnnualMeetung be back! Plenary 1: News you can use. Thank you Matt Powell Bhavana Pothuri for chairing and making sure we get all the information we need in a timely fashion. #SGO2024

Patient Perspective on Tisotumab Vedotin Grateful Jennifer Clark could share her experience with TV during the Plenary session. She celebrated so many milestones after her treatment- Thanks to the research being done by SGO members! #gyncsm #SGOmtg

TROP-2 #ADC Sacituzumab in phase II EVER trial from China shows impressive ORR of 50%-No CRs unlike Tidvak (Tissue factor ADC) but PR of 50% vs 24% in TV and comparable DOR 9 vs 8mo in TV. Hmmmm... how to choose if these become available globally #SGOMtg #gyncsm

The menopause session at #SGOmtg is excellent! And it’s a packed house with tons standing in the back. Thank you for recognizing the need for education on this!

An inspirational message Michael Frumovitz MD Anderson Cancer Center, we applaud your bravery, courage, strength, and passion always 💜 #SGOMtg #FrumoFighters

Assessment of NIH Research on Womens Health | National Academies. Check this out!!! Women’s health research continues to be grossly underfunded and despite NIH efforts has only gotten worse. Call for radical change at the NIH!! nationalacademies.org/our-work/asses…

Meet Dr. Nadeem Abu-Rustum (USA), IGCS President Elect! View the IGCS Board of Directors here: igcs.org/leadership/

Meet Karen Lu, MD (Karen Lu) who joined Moffitt in June 2024 as the physician in chief. She is a nationally recognized physician-scientist who specializes in advancing care for women with ovarian and endometrial cancers. Learn more: bit.ly/4gjmAhx

I’m so proud to launch the Italian version of Olivia at #ESGO2025 today! Olivia is a digital support tool for our ovarian cancer patients & their loved ones that guides them through diagnosis & treatment. ovarian.gynecancer.org/it

We are deeply saddened by the passing of Dr. Giovanni Scambia, a highly respected leader in the gynecologic oncology community and a valued member of IGCS. Dr. Scambia contributed immensely to our society, participating in multiple IGCS Annual Global Meetings as an attendee,

So excited to see the gentle giant be recognized at #SGO 2025 annual meeting for contributions to the field particularly in rare ovarian tumors. John Farley also faithfully service our country as a colonel in the US military. Congratulations John! ⁦⁦Vaniam Group LLC⁩

#SGOMtg- on the scene with Dr Fiona Simpkins to discuss impact of her work exploring WEE1 inhibition in CCNE1-expressing #ovariancancer #gyncsm #SGO2025 Nicole D. Fleming MD Eric Rios-Doria, MD erin medlin

Our first interview of the day was with Linda Duska of UVA Medicine, who shared key OS and PFS2 data from the second interim analysis of the KEYNOTE-A18 study. Hear a brief preview of her research below, and check out onclive.com for more details! SGO #SGOMtg #gynsm

💥Post-session highlights from Drs. Hanley and McAlpine with updates on opportunistic #salpingectomy in Canada! 🇨🇦 #SGOMtg #SGO2025

Congratulations to our Physician In Chief, Karen Lu!

Join us in congratulating Karen Lu, MD (@KarenLuMD), Moffitt’s Physician in Chief, as she takes the helm as President of SGO! This opportunity highlights her dedication to advancing gynecologic cancer care, driving innovation and saving lives. 👏🎉